Despite advances in hearing technology and satisfaction rates, new Eurotrak UK 2025 data reveals that many people still avoid getting hearing instruments for the same reasons as in years past.
Audiology Australia welcomes the federal government’s decision to register audiology under the National Registration and Accreditation Scheme.
HIA's MarkeTrak 2025 study of the U.S. hearing loss market provides new data on prescription hearing aids, OTC devices, and emerging technologies.
Widex earned two top honors in the 2025 Hearing Technology Innovator Awards for its AI-powered Widex Allure App and its cloud-based Compass Cloud fitting platform.
The Audiology Practice Standards Organization is inviting public review and comment on its new draft standard to ensure profession-supported best practices in tinnitus evaluation.
Neuromod Devices has achieved both Medical Device Single Audit Program (MDSAP) and EU Medical Device Regulation (MDR) certification, enabling expanded global availability of its Lenire tinnitus treatment device in Europe, Canada, Australia, and beyond.
ESCO has appointed a new director of commercial insurance to lead its expanding suite of business coverage solutions.
A new study has identified how electrical charges in the inner ear trigger TMPRSS3-related hearing loss—and found that a common drug may help prevent it.
Doctoral students in Audiology from across the U.S. attended the 2025 Oticon Summer Camp for real-world clinical practice and career development.